Vanguard Group Inc Zomedica Corp. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Zomedica Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 48,326,991 shares of ZOM stock, worth $5.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,326,991

Previous 48,326,991 -0.0%

Holding current value

$5.8 Million

Previous $7.25 Million 6.68%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.12 - $0.19 $69,199 - $109,565	-576,660 Reduced 1.18%	48,326,991 $7.25 Million
Q4 2023 Mar 11, 2024	BUY	$0.15 - $0.22 $9 - $13	62 Added 0.0%	48,903,651 $9.78 Million
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.22 $14,340 - $21,032	95,600 Added 0.2%	48,903,589 $9.78 Million
Q2 2023 Aug 14, 2023	SELL	$0.19 - $0.22 $34,121 - $39,508	-179,586 Reduced 0.37%	48,807,989 $9.76 Million
Q1 2023 May 15, 2023	BUY	$0.16 - $0.29 $26,768 - $48,518	167,305 Added 0.34%	48,987,575 $10.3 Million
Q4 2022 Feb 10, 2023	BUY	$0.16 - $0.25 $398,602 - $622,816	2,491,265 Added 5.38%	48,820,270 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$0.2 - $0.38 $450,530 - $856,007	2,252,651 Added 5.11%	46,329,005 $9.78 Million
Q2 2022 Aug 12, 2022	BUY	$0.2 - $0.34 $693,842 - $1.18 Million	3,469,211 Added 8.54%	44,076,354 $9.7 Million
Q1 2022 May 13, 2022	SELL	$0.28 - $0.4 $287,990 - $411,415	-1,028,539 Reduced 2.47%	40,607,143 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$0.31 - $0.58 $56,220 - $105,187	181,358 Added 0.44%	41,635,682 $12.8 Million
Q3 2021 Nov 12, 2021	SELL	$0.46 - $0.81 $481,581 - $848,002	-1,046,917 Reduced 2.46%	41,454,324 $21.7 Million
Q2 2021 Aug 13, 2021	BUY	$0.72 - $1.46 $30.6 Million - $62.1 Million	42,501,241 New	42,501,241 $35.4 Million

Others Institutions Holding ZOM

# of Institutions

Shares Held

80.9M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $118M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Zomedica Corp. Transaction History